 |
|
|
FORUM « "Looking Under the Hood" of the State Farm Katrina Settlement | Hospital chief: liability curbs rev up W.V. medicine » January 30, 2007Vioxx litigation bill: $500M for 2006 Just about every press account of Merck's 2006 earnings report has listed the litigation expense reserve, but not the actual litigation expenditures. This figure was announced on the conference call (via WSJ): During 2006, the Company spent $500 million in the aggregate, including $175 million in the fourth quarter, in legal defense costs worldwide related to Vioxx litigation.Posted by Ted Frank at 07:05 PM | TrackBack (0) |
|
|
Published by the Manhattan Institute
| ||
